High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

In typical pharmacoepidemiologic studies, the proposed high-dimensional propensity score resulted in improved effect estimates compared with adjustment limited to predefined covariates, when benchmarked against results expected from randomized trials.